Christophe Chassagnole

Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK.

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.

Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom.

City Capital Corp. Ltd. provides brokerage services. The private company is based in London, UK. and has subsidiaries in Bermuda. The British company was founded in 2002. David C. Meacher has been the CEO of the company since 2003.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

Equity Development Ltd. is an investment research firm headquartered in London, UK. The firm was founded by Brian Basham in 1997 and is a subsidiary of Equity Holdings Ltd., which is owned by Bashco Ltd. Equity Development provides investors of all types with freely available equity research and direct access to quoted companies’ management.

Edison Investment Research Ltd. (Edison) is an investment research, investor relations and consulting firm headquartered in London, UK. The firm was founded by Stephen Rogers and Fraser Thorne in 2003. They are a subsidiary of Edison Global Ltd. Edison provides investment research to international investors, advisors and stakeholders.

Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The company is based in Maidenhead, UK. Founded in 1987.

Part of Boston Scientific Corp., Provensis Ltd. is a British company that provides health care services. The company is based in Camberley, UK. The company was founded in 1999 by Paul Bernard Harper.

Food & Drug Analytical Services Ltd. provides pharmaceutical quality control testing services. Its services include raw material, product release, and stability testing, microbiology, and development services. The firm also offers analytical methodologies, ICH stability storage, development and validation services. The company was founded in 2004 and is headquartered in Nottingham, the United Kingdom.

Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK

HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France.

Albany Molecular Research (UK) Ltd. manufacture of pharmaceutical preparations. The company is headquartered in Holywell, the United Kingdom.

Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.

Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom.

Oval Medical Technologies Ltd. manufactures drug delivery devices focusing on vials, prefilled syringes, and autoinjectors. It provides an environment for the storage of all drugs including fragile biologics. The company was founded by Matthew Young in 2009 and is headquartered in Cambridge, the United Kingdom.

Proactive Investors Ltd. is a financial media portal that connects companies and investors. The company is based in London, UK, and has subsidiaries in the United States. The British company provides breaking news, commentary, and analysis on hundreds of listed companies and pre-IPO businesses globally, 24/7. The company offers in-depth comment, analysis, press releases, and share price data on small to large capitalized companies. Proactive is one of the fastest-growing financial media portals in the world, leading in up-to-the-minute, multi-media news provision, events organization, and investor research. The company was founded in 2006 by Craig Ribton, who has been the CEO since 2006.

Geoscience Wales Ltd. promotes the geoscience businesses Associate members’ through marketing their geoscience expertise and services in the broader commercial marketplace. The company was founded in 2001 and is headquartered in Conwy, the United Kingdom.

Neurocentrx Pharma Ltd. is a British pharmaceutical company that manufactures and distributes medicines. The company is based in Edinburgh, UK. Neurocentrx Pharma was founded by Howard Marriage, Ronald M. Lindsay, and Carmel Reilly. Carmel Reilly has been the CEO since incorporation.

Kinapse Ltd. provides consulting and outsourcing services to the life sciences industry. It offers quality and compliance, research and development operations, life science policy, medical writing, medical information, and market access services. The company was founded by Andrew Black and Shalabh Kumar in 2005 and is headquartered in London, the United Kingdom.

Part of Jazz Pharmaceuticals Plc, Eusa Pharma International Ltd. is a Gibraltar specialty biopharmaceutical company that identifies, develops, and commercializes pharmaceutical products.

Clustermarket Ltd. operates an online sharing platform for life scientists to list, discover and book resources within their institution or cluster. The company was founded by Tobias Wingbermühleand Johannes Solzbach and is headquartered in London, the United Kingdom.

Part of Roivant Sciences Ltd., Izana Bioscience Ltd. is a British biotech company. The company is based in London, UK. The company's website, izanabio.com, provides general information about the company. The company was founded in 2017 by Someit Sidhu. Someit Sidhu has been the CEO since 2017.

Navitas Life Sciences, Inc. is a full-service clinical trial CRO that offers regulatory support, phases I-IV, and pharmacovigilance services. The company is based in Princeton, NJ. The company's Signal Management Services are provided by a team of highly qualified pharmacovigilance experts who work with clients to detect, validate, assess, and track signals. Navitas Life Sciences also supports virtual clinical trials, COVID-19, infectious disease, and more. The CEO of the company is Srinivasan H. R.